KAZIA THERAPEUTICS LTD Logo

KAZIA THERAPEUTICS LTD

Oncology-focused biotech developing targeted therapies for cancers with high unmet needs.

KZIA | US

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
United States of America
Address:
THREE INTERNATIONAL TOWERS LEVEL 24,, 2000 SYDNEY NSW

Description

Kazia Therapeutics Ltd. is an oncology-focused biotechnology company engaged in the development of innovative drugs for cancer. The company's lead program is paxalisib, a small molecule inhibitor of the PI3K/AKT/mTOR pathway designed to cross the blood-brain barrier, which is being investigated for various forms of brain cancer. Its development pipeline also includes EVT801, a selective VEGFR3 inhibitor being studied for its potential to block the growth of blood and lymphatic vessels that support tumor growth. The company focuses on addressing cancers with high unmet medical needs through its portfolio of targeted therapies.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2009-03-18 12:52
FORM 6K 2009 03 19 2
English 22.7 KB
2009-03-18 12:50
FORM 6K 2009 03 19
English 21.0 KB
2009-02-27 23:25
FORM 6K 2009 02 27
English 296.7 KB
2009-02-27 19:58 English 22.2 KB
2009-02-24 23:14
FORM 6K 2008 02 24
English 24.0 KB
2009-02-24 18:23 English 40.4 KB
2009-02-14 00:03
FORM 6K 2009 02 13
English 20.1 KB
2009-01-07 12:09
FORM 6K 2008 01 07
English 19.4 KB
2008-12-05 14:01
20-F
English 235.6 KB
2008-12-01 12:08
FORM 6K 2008 12 01 1
English 23.5 KB
2008-12-01 12:04
FORM 6K 2008 12 01
English 24.9 KB
2008-11-18 00:12
FORM 6K 2008 11 13
English 26.1 KB
2008-11-05 23:30
FORM 6K 2008 11 05
English 20.7 KB
2008-11-03 12:08
FORM 6K 2008 11 03
English 26.5 KB
2008-11-03 12:04
FORM 6K 2008 10 31
English 25.9 KB

Automate Your Workflow. Get a real-time feed of all KAZIA THERAPEUTICS LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for KAZIA THERAPEUTICS LTD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for KAZIA THERAPEUTICS LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Keros Therapeutics, Inc. Logo
Develops protein therapeutics for disorders linked to TGF-β signaling.
United States of America
KROS
Kura Oncology, Inc. Logo
Clinical-stage biopharma company developing precision medicines for cancer treatment.
United States of America
KURA
Larimar Therapeutics, Inc. Logo
A clinical-stage biotech developing treatments for complex rare diseases.
United States of America
LRMR
Lexaria Bioscience Corp. Logo
A biotech company with a patented platform to improve oral drug delivery and absorption.
United States of America
LEXX
LigaChem Biosciences Inc. Logo
Clinical-stage biopharma developing ADCs, immuno-oncology drugs, and small molecules.
South Korea
141080
Linical Co., Ltd. Logo
A global CRO providing a full spectrum of drug development services for biopharma.
Japan
2183
Lipigon Pharmaceuticals AB Logo
A clinical-stage company developing therapeutics for lipid-related disorders.
Sweden
LPGO
Lipum AB Logo
Clinical-stage biopharma developing novel treatments for chronic inflammatory diseases.
Sweden
LIPUM
LIXTE BIOTECHNOLOGY HOLDINGS, INC. Logo
Clinical-stage pharma company developing PP2A inhibitors to enhance cancer therapies.
United States of America
LIXT
Pre-clinical biotech company using AI for drug discovery and biodefense.
United States of America
RENB

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.